Literature DB >> 12324849

Impurity profiling of seized MDMA tablets by capillary gas chromatography.

Fabien Palhol1, Sophie Boyer, Norbert Naulet, Martine Chabrillat.   

Abstract

Impurity profiles of 3,4-methylenedioxymethylamphetamine (MDMA) tablets seized in France have been examined. The samples were extracted with methylene chloride under basic conditions and then analyzed by capillary gas chromatography. Almost 30 compounds were identified as precursors, intermediates and by-products. Palmitic and stearic acid were also found as tableting materials. The comparison of the different profiles obtained by the reported procedure provided very useful information about the synthetic processes used by clandestine laboratories and enabled a classification into several groups of profiles. According to these results, the reductive amination route appears to be the most common synthetic pathway in Western Europe. Furthermore, 3,4-methylenedioxyphenyl-2-propanone seems to be the most used precursor in clandestine laboratories.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12324849     DOI: 10.1007/s00216-002-1477-6

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  3 in total

1.  Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.

Authors:  Michael A Taffe; Christopher C Lay; Stefani N Von Huben; Sophia A Davis; Rebecca D Crean; Simon N Katner
Journal:  Drug Alcohol Depend       Date:  2005-11-11       Impact factor: 4.492

2.  Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.

Authors:  Erin A Kolbrich; Robert S Goodwin; David A Gorelick; Robert J Hayes; Elliot A Stein; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2008-06       Impact factor: 3.681

3.  Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.

Authors:  Allan J Barnes; Bruno S De Martinis; David A Gorelick; Robert S Goodwin; Erin A Kolbrich; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-01-23       Impact factor: 8.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.